Doctor profile · Federal record
Dr. Jeanne Steppel-Reznik, MD
Endocrinology, Diabetes & Metabolism Physician (CMS: Endocrinology) · Internal Medicine Physician · Boston, MA
- NPI 1366410334
- Accepts Medicare
- 28 yrs in practice
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
50 Staniford Street, 3Rd Floor Diabetes Unit
Boston, MA 02114
(617) 726-8722
fax (617) 724-8534 - Mailing address
-
Po Box 9142, Mass General Physician Organization
Charlestown, MA 021299142
Credentials & registration
- NPI registered
- March 2006 — 20 yrs on file
- Profile last updated
- November 7, 2012
- Year of graduation
- 1998 — 28 yrs since
- Specialty taxonomy
- 207RE0101X — NUCC code
- State license (1)
- Massachusetts #217569
- Medicaid
- MA #2083833
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1366410334. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
351
Distinct HCPCS
3
Medicare allowed
$45,738
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 151 | 123 | $140 | |
99215 |
Established patient office or other outpatient visit, 40-54 minutes | 108 | 88 | $196 | |
95251 |
Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | 92 | 65 | $37 |
In context: peer comparison
Among 97 peers in Boston Endocrinology, Diabetes & Metabolism Physician, average services per provider: 116. This provider delivers 3.0× the peer median.Open Payments
Industry payments received
All-time total
$32
Transactions
1
Manufacturers
1
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Novo Nordisk INC | 1 | $32.27 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
859
Patients
312
Total drug cost
$583,043
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Metformin Hcl ER (Metformin Hcl) | Brand | 113 | 38 | $2,255 |
| Levothyroxine Sodium | Generic | 111 | 43 | $2,015 |
| Trulicity (Dulaglutide) | Brand | 106 | 31 | $159,105 |
| Jardiance (Empagliflozin) | Brand | 76 | 27 | $105,577 |
| Lantus Solostar (Insulin Glargine,Hum.Rec.Anlog) | Brand | 67 | 25 | $52,778 |
| Metformin Hcl | Generic | 54 | 23 | $1,300 |
| Ozempic (Semaglutide) | Brand | 54 | 16 | $96,156 |
| Glipizide ER (Glipizide) | Brand | 44 | 16 | $1,973 |
| Humalog Kwikpen U-100 (Insulin Lispro) | Brand | 43 | 19 | $43,204 |
| Nano 2Nd Gen Pen Needle (Pen Needle, Diabetic) | Brand | 36 | 21 | $2,692 |
Hospital affiliations
Frequently asked questions
What is Dr. Jeanne Steppel-Reznik's medical specialty?
Dr. Jeanne Steppel-Reznik practices Endocrinology, Diabetes & Metabolism Physician in Boston, MA.
Where does Dr. Jeanne Steppel-Reznik practice?
Dr. Jeanne Steppel-Reznik practices at 50 Staniford Street, Boston, MA 02114. Office phone: 6177268722.
What is Dr. Jeanne Steppel-Reznik's NPI?
Dr. Jeanne Steppel-Reznik's National Provider Identifier (NPI) is 1366410334, issued by NPPES.
Does Dr. Jeanne Steppel-Reznik accept Medicare assignment?
Yes. Dr. Jeanne Steppel-Reznik accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Jeanne Steppel-Reznik commonly perform?
Top Medicare-reported procedures in 2023: Established patient office or other outpatient visit (HCPCS 99214); Established patient office or other outpatient visit (HCPCS 99215); Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report (HCPCS 95251). Source: CMS Medicare Physician & Other Practitioners file.